Biolife Solutions (BLFS) Short-term Investments (2014 - 2026)

Biolife Solutions (BLFS) has 9 years of Short-term Investments data on file, last reported at $58.2 million in Q1 2026.

• Quarterly Short-term Investments rose 168.89% year-over-year to $58.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.2 million (up 168.89% YoY) and the FY2025 annual result came in at $55.9 million, up 507.62% from the prior year.
• Short-term Investments advanced to $58.2 million in Q1 2026 per BLFS's latest filing, from $55.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $58.2 million in Q1 2026 and bottomed at $10000.0 in Q1 2022.
• The 5-year median for Short-term Investments is $16.3 million (2023), against an average of $21.8 million.
• The widest annual swing landed in 2023, when Short-term Investments plunged 99.91%; it then jumped 160751.61% in 2025.
• Tracing BLFS's Short-term Investments over 5 years: stood at $43.3 million in 2022, then tumbled by 62.35% to $16.3 million in 2023, then plunged by 43.53% to $9.2 million in 2024, then jumped by 507.62% to $55.9 million in 2025, then rose by 4.09% to $58.2 million in 2026.
• Per Business Quant, the three latest BLFS Short-term Investments figures stand at $58.2 million (Q1 2026), $55.9 million (Q4 2025), and $49.5 million (Q3 2025).

Peer Comparison